The Role of Brain-Derived Neurotrophic Factor in Epileptogenesis: an Update

Bibliographic Details
Title: The Role of Brain-Derived Neurotrophic Factor in Epileptogenesis: an Update
Authors: Xinyi Wang, Zhe Hu, Kai Zhong
Source: Frontiers in Pharmacology, Vol 12 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: epilepsy, brain-derived neurotrophic factor, tyrosine kinase receptor B, treatment target, epileptogenesis, Therapeutics. Pharmacology, RM1-950
More Details: Epilepsy, which is characterized by spontaneous recurrent seizures, is one of the most common and serious chronic neurological diseases in the world. 30% patients failed to control seizures with multiple anti-seizure epileptic drugs, leading to serious outcomes. The pathogenesis of epilepsy is very complex and remains unclear. Brain-derived neurotrophic factor (BDNF), as a member of the neurotrophic factor family, is considered to play an important role in the survival, growth and differentiation of neurons during the development of the central nervous system. Recent years, a series of studies have reported that BDNF can maintain the function of the nervous system and promotes the regeneration of neurons after injury, which is believed to be closely related to epileptogenesis. However, two controversial views (BDNF inhibits or promotes epileptogenesis) still exist. Thus, this mini-review focuses on updating the new evidence of the role of BDNF in epileptogenesis and discussing the possibility of BDNF as an underlying target for the treatment of epilepsy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.758232/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2021.758232
Access URL: https://doaj.org/article/91635fc921934fc6ad5deed19f37c83d
Accession Number: edsdoj.91635fc921934fc6ad5deed19f37c83d
Database: Directory of Open Access Journals
More Details
ISSN:16639812
DOI:10.3389/fphar.2021.758232
Published in:Frontiers in Pharmacology
Language:English